Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droxidopa + Carbidopa in Adult ADHD
NCT00983814Phase 2Completed
- Sponsor
- Chelsea Therapeutics International, Ltd.
- Start
- Oct 2009
- Primary completion
- May 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Droxidopa + Carbidopa with Placebo (2 arms). Primary endpoint: Adult ADHD Investigator Symptom Rating Scale Total Score at Week 8. Started Oct 2009; status: completed.
02
Drugs
droxidopa
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00983814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00983814.